CRIS Current Research Information System

STAGNI, FIORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.755
AS - Asia 2.717
EU - Europa 1.822
AF - Africa 211
SA - Sud America 115
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.716
SG - Singapore 854
VN - Vietnam 723
IT - Italia 710
CN - Cina 634
GB - Regno Unito 270
DE - Germania 225
HK - Hong Kong 160
SE - Svezia 106
FR - Francia 92
IN - India 91
NL - Olanda 88
BR - Brasile 82
CI - Costa d'Avorio 62
TG - Togo 58
IE - Irlanda 56
KR - Corea 56
RU - Federazione Russa 51
JP - Giappone 46
ZA - Sudafrica 46
FI - Finlandia 43
PH - Filippine 30
BG - Bulgaria 27
CH - Svizzera 24
JO - Giordania 23
BE - Belgio 22
CA - Canada 22
UA - Ucraina 21
BD - Bangladesh 20
SC - Seychelles 19
AR - Argentina 18
TH - Thailandia 18
AT - Austria 17
EE - Estonia 16
MX - Messico 13
PL - Polonia 10
GR - Grecia 9
ID - Indonesia 9
TR - Turchia 9
ES - Italia 8
IQ - Iraq 8
LT - Lituania 8
NG - Nigeria 7
SA - Arabia Saudita 6
TW - Taiwan 6
AU - Australia 5
CL - Cile 4
EC - Ecuador 4
IR - Iran 4
KE - Kenya 4
MY - Malesia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ET - Etiopia 3
HR - Croazia 3
RO - Romania 3
AL - Albania 2
CO - Colombia 2
HU - Ungheria 2
MA - Marocco 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SD - Sudan 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.626
Salva come PNG Salva come JPEG
Città #
Singapore 591
Ashburn 303
Bologna 259
Chandler 258
Fairfield 237
Southend 231
Hanoi 180
Ho Chi Minh City 176
Hong Kong 143
San Jose 142
Santa Clara 137
Houston 130
Hefei 122
Seattle 115
Wilmington 114
Ann Arbor 107
Woodbridge 96
Beijing 78
Cambridge 68
Abidjan 62
Princeton 60
Frankfurt am Main 58
Lomé 58
Dublin 56
Boardman 52
Dong Ket 47
Los Angeles 45
New York 44
Seoul 42
Turin 41
Lauterbourg 37
Tokyo 35
Redmond 33
Council Bluffs 32
Helsinki 32
Dallas 31
Milan 30
Falls Church 29
Rimini 29
Sofia 27
Buffalo 25
Johannesburg 25
Da Nang 24
Amman 23
Haiphong 23
Bern 21
Brussels 21
Munich 21
Rome 21
Westminster 21
Nanjing 19
Shanghai 17
Padova 16
Chicago 15
Guangzhou 15
Jinan 15
San Diego 15
Shenyang 15
Tianjin 15
Amsterdam 14
Berlin 14
Bengaluru 13
Vienna 12
Hải Dương 11
Redondo Beach 11
Trento 11
Bolzano 10
Redwood City 10
Saint Petersburg 10
Changsha 9
Florence 9
Ha Long 9
Hebei 9
London 9
Orem 9
Phoenix 9
Toronto 9
Udine 9
Wuhan 9
Zhengzhou 9
Des Moines 8
Meldola 8
São Paulo 8
Bangkok 7
Bắc Ninh 7
Nanchang 7
Naples 7
Ninh Bình 7
San Francisco 7
Biên Hòa 6
Jakarta 6
Lappeenranta 6
Manila 6
Mexico City 6
Olalla 6
Paris 6
Portsmouth 6
Qingdao 6
The Dalles 6
Abeokuta 5
Totale 5.080
Salva come PNG Salva come JPEG
Nome #
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 305
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 301
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 261
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 245
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 234
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 234
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 227
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 223
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 222
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 218
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 216
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 214
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 208
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 203
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 200
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 194
Effect of adolescent treatment with the flavonoid 7,8-DHF on brain wiring, synaptic plasticity and cognitive performance in a model of Down syndrome 189
SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation 185
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 183
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 178
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 177
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 176
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 173
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 167
Timing of therapies for downsyndrome: The sooner, the better 161
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 159
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 155
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model 153
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 145
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome 144
Dendritic phenotype and proliferation potency in the hippocampal dentate gyrus of the Ts66Yah model of Down syndrome 132
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives 132
null 130
Targeting APP/AICD in Down syndrome 130
Neurogenesis impairment: An early developmental defect in Down syndrome 121
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 116
null 97
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 96
Advocating for increased awareness and research on Down syndrome 85
null 83
“Analisi dell’espressione genica in ippocampi di topi Ts65Dn sottoposti a trattamento adolescenziale con il BDNF-mimetico 7,8 diidrossiflavone” 72
“Il trattamento adolescenziale con il BDNF mimetico 7,8-diidrossiflavone influenza la metilazione del DNA nell'ippocampo del modello Ts65Dn di sindrome di Down” 60
“Effects of 7,8-dihydroxyflavone treatment on DNA methylation profiles of adolescent Ts65Dn mice hippocampus” 58
“Administration of the BDNF mimetic 7,8-Dihydroxyflavone during adolescence rescues neuron maturation and improves hippocampus- dependent memory in the Ts65Dn mouse model of Down syndrome”. 57
“Trattamento adolescenziale con il BDNF mimetico 7,8- diidrossiflavone: una strategia utile per migliorare lo sviluppo della fascia dentata ippocampica nel modello Ts65Dn di sindrome di Down”. 50
“Is it possible to prevent or counteract Alzheimer’s disease in Down syndrome with molecules with antioxidant and anti-inflammatory properties?” 48
“Trattamento neonatale con astaxantina veicolata tramite nanoparticelle: effetti sullo sviluppo ippocampale e sullo stress ossidativo nel modello murino Ts65D” 47
“Early pharmacotherapies for the rescue of intellectual disability in Down syndrome” 46
“Il trattamento con il polifenolo Polidatina migliora lo sviluppo cerebrale e la memoria ippocampo-dipendente nel topo Ts65Dn, modello di sindrome di Down” 45
“La somministrazione neonatale di astaxantina tramite nanoparticelle ha un effetto proproliferativo nel modello murino Ts65Dn” 45
“Adolescence represents an important window of opportunity for the rescue of dendritic pathology with a BDNF mimetic in a mouse model of Down syndrome” 44
“Effects of neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles on hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome” 41
“Neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles fosters hippocampal neurogenesis in a mouse model of Down syndrome” 38
Totale 7.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 0 25 95
2021/2022584 33 27 25 15 68 42 55 35 26 37 110 111
2022/2023960 74 161 52 121 62 77 37 57 147 15 79 78
2023/2024284 21 46 17 29 15 55 3 5 3 21 41 28
2024/20251.218 76 88 98 85 179 50 131 66 37 96 106 206
2025/20263.236 311 223 203 237 340 288 307 168 761 281 117 0
Totale 7.823